COVID-19 Breakthrough: An Inhaled Drug May Reduce the Risk of Complications by 79%

Synairgen a British laboratory has developed a drug that could reduce the risk of developing a serious form of the disease caused by Covid-19 by 79%. This could revolutionize the treatment of COVID-19 patients: The British laboratory Synairgen announced on Monday that it has developed a drug capable of reducing the risk of developing the serious form of the disease caused by COVID-19 by 79%. Read Also: Far-UVC Light That Is Harmless to Humans Kills Airborne Coronaviruses and Flu Viruses At the end of a study of 101 participants in 9 different British hospitals, the researchers obtained “very significant” results: This … Continue reading COVID-19 Breakthrough: An Inhaled Drug May Reduce the Risk of Complications by 79%